Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Weiss Michael S
Relationship:   Director
City:   Berkeley Heights
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   16,329,233    

Indirect Shares

   14,546,388      
Direct Value   $207,679,882    

Indirect Value

   $228,994,301      
Total Shares   30,875,621      
Total Value   $436,674,183      


Keryx Biopharmaceuticals Inc $0 Genta Inc De $0 XTL Biopharmaceuticals Ltd $56,750 TG Therapeutics Inc $207,237,625 Fortress Biotech, Inc. $385,507 Avenue Therapeutics, Inc. $0 Keryx Biopharmaceuticals Inc $0 Genta Inc De $0 XTL Biopharmaceuticals Ltd $56,750 TG Therapeutics Inc $207,237,625 Fortress Biotech, Inc. $385,507 Avenue Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    2    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   0.0   
   -2.0   
     Percentage Gain/Loss :
   -2.8%
 -135.7%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Keryx Biopharmaceuticals Inc KERX 10% Owner 2010-05-10 1,320,418 2003-11-21 0    Premium*  
            Genta Inc De GNTAQ Director 2005-08-05 537,238 2004-07-14 0    Premium*  
            XTL Biopharmaceuticals Ltd XTLBY Director 2008-08-22 25,000 0    Premium*  
            TG Therapeutics Inc TGTX CEO 2024-01-06 13,074,929 2020-06-22 14,434,214    Premium*  
            Fortress Biotech, Inc. FBIO See Remarks, Director,... 2024-01-01 1,346,985 2013-12-19 0    Premium*  
            Checkpoint Therapeutics, Inc. CKPT Director 2017-06-15 0 2024-05-14 112,174    Premium*  
            Avenue Therapeutics, Inc. ATXI Director 2018-08-07 24,663 0    Premium*  
* Premium Members only  

Records found :    126         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
KERX Keryx Biopharmaceuticals ... Chairman and CEO   •       •      –    2006-12-08 4 OE $1.30 $35,233 D/D 27,102 42,102 0 -
KERX Keryx Biopharmaceuticals ... Chairman and CEO   •       •      –    2006-12-11 4 OE $1.30 $29,764 D/D 22,895 37,895 0 -
KERX Keryx Biopharmaceuticals ... Chairman and CEO   •       •      –    2006-12-12 4 OE $1.30 $19,500 D/D 15,000 30,000 0 -
KERX Keryx Biopharmaceuticals ... Chairman and CEO   •       •      –    2006-12-13 4 OE $1.30 $27,738 D/D 21,337 36,337 0 -
KERX Keryx Biopharmaceuticals ... Chairman and CEO   •       •      –    2006-12-14 4 OE $1.30 $29,753 D/D 22,887 37,887 0 -
KERX Keryx Biopharmaceuticals ... Chairman and CEO   •       •      –    2006-12-15 4 OE $1.30 $33,063 D/D 25,433 40,433 0 -
KERX Keryx Biopharmaceuticals ... Chairman and CEO   •       •      –    2006-12-18 4 OE $1.30 $15,484 D/D 11,911 26,911 0 -
KERX Keryx Biopharmaceuticals ... 10% Owner   –       –       •   2010-04-05 4 OE $1.30 $260,000 D/D 200,000 1,968,167 0 -
KERX Keryx Biopharmaceuticals ... 10% Owner   –       –       •   2010-04-12 4 OE $1.30 $195,000 D/D 150,000 1,968,167 0 -
FBIO Fortress Biotech, Inc. See Remarks   •       •      –    2023-11-14 4 B $1.70 $249,999 D/D 147,058 1,130,520 2.81 -
KERX Keryx Biopharmaceuticals ... Chief Executive Officer   •       •      –    2003-06-04 4 B $1.75 $8,750 D/D 5,000 15,000 2.81 -
TGTX TG Therapeutics Inc See Remarks   •       •       •   2012-09-10 4 B $2.25 $112,500 D/D 50,000 7,242,728 3.23 -
TGTX TG Therapeutics Inc See Remarks   •       •       •   2012-09-11 4 B $2.25 $225,000 D/D 100,000 7,342,728 3.23 -
KERX Keryx Biopharmaceuticals ... 10% Owner   –       –       •   2009-02-03 5 S $2.70 $69,428 D/D (25,714) 1,887,986 0 -
KERX Keryx Biopharmaceuticals ... 10% Owner   –       –       •   2009-01-28 5 S $3.06 $156,978 D/D (51,300) 1,913,700 0 -
KERX Keryx Biopharmaceuticals ... 10% Owner   –       –       •   2009-12-07 5 S $3.30 $544,500 D/D (165,000) 1,722,986 0 -
TGTX TG Therapeutics Inc See Remarks   •       •       •   2013-12-11 4 B $3.43 $34,300 D/D 10,000 7,839,471 3.23 -
KERX Keryx Biopharmaceuticals ... 10% Owner   –       –       •   2010-04-05 4 S $3.58 $1,038,558 D/D (290,100) 1,768,167 0 -
KERX Keryx Biopharmaceuticals ... 10% Owner   –       –       •   2010-04-12 4 S $4.12 $618,000 D/D (150,000) 1,818,167 0 -
KERX Keryx Biopharmaceuticals ... Chief Executive Officer   •       •      –    2003-11-21 4 B $4.22 $21,261 D/D 5,000 10,000 2.81 -
KERX Keryx Biopharmaceuticals ... 10% Owner   –       –       •   2010-04-23 4 S $4.41 $377,893 D/D (85,690) 1,862,377 0 -
KERX Keryx Biopharmaceuticals ... 10% Owner   –       –       •   2010-04-29 4 S $4.63 $667,831 D/D (144,240) 1,718,137 0 -
KERX Keryx Biopharmaceuticals ... 10% Owner   –       –       •   2010-04-13 4 S $4.80 $96,480 D/D (20,100) 1,948,067 0 -
KERX Keryx Biopharmaceuticals ... 10% Owner   –       –       •   2010-04-30 4 S $5.53 $569,590 D/D (103,000) 1,615,137 0 -
KERX Keryx Biopharmaceuticals ... 10% Owner   –       –       •   2010-05-06 4 S $5.59 $262,730 D/D (47,000) 1,418,137 0 -
  126  Records found
  1   2   3   4  5   6      
  Page 4 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us